Related Experiment Video
Updated: Jun 27, 2025
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.3K
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper
Oliver Pfaar1, Bernardo Sousa-Pinto2,3, Nikolaos G Papadopoulos4
1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Allergy
|May 3, 2024
Summary
Mobile health (mHealth) apps show promise for improving person-centred care (PCC) in allergen immunotherapy (AIT) for rhinitis and asthma. Validation is needed, but these tools can aid AIT initiation, efficacy evaluation, and treatment monitoring.
Area of Science:
- Allergy and Clinical Immunology
- Digital Health
- Respiratory Medicine
Background:
- Numerous mHealth applications exist for rhinitis and asthma management, yet few have undergone rigorous validation.
- These digital tools possess significant potential to enhance person-centred care (PCC) within allergen immunotherapy (AIT).
Purpose of the Study:
- To explore the clinical applications and potential of mHealth solutions in AIT.
- To identify current limitations of mHealth in AIT.
- To propose future developments for clinical practice and scientific research in digital AIT.
Main Methods:
- Review of existing mHealth applications for rhinitis and asthma.
- Analysis of potential roles in AIT initiation, efficacy assessment, and treatment monitoring.
- Consideration of digital biomarkers and shared decision-making frameworks.
Main Results:
- mHealth apps can support patient selection and shared decision-making for AIT initiation.
- These tools can facilitate the evaluation of early and sustained treatment efficacy, including stopping rules.
- Digital biomarkers are crucial for future mHealth development in AIT.
Conclusions:
- Validated mHealth solutions offer a promising avenue for digitally-enabled PCC in AIT.
- Further development and validation are essential to fully realize the potential of mHealth in allergy care.
- Specific tools need to be identified and adapted for effective implementation in clinical practice.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
02:06Allergic Reactions
27.3K
Overview
27.3K
01:30Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
01:20Asthma: Pathogenesis and Management
390
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
390
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K